Rule 31, The Drugs and Cosmetics Rules, 1945: Standard for certain imported drugs
The Drugs and Cosmetics Rules, 1945 - Rule 31
Text of rule 31
Standard for certain imported drugs
[31. Standard for certain imported drugs.—No drug shall be imported unless it
complies with the standard of strength, quality and purity, if any, and the test
prescribed in the Rules shall be applicable for determining whether any such imported
drug complies with the said standard:
Provided that the drugs intended for veterinary use, the standards of strength,
quality and purity, if any, shall be those that are specified in Schedule F(1) and the
test prescribed in that Schedule shall be applicable for determining whether any such
imported drug complies with the said standards and where no standards are specified
in Schedule F(1) for any veterinary drug, the standards for such drug shall be those
specified in the current edition, for the time being in force, of the British
Pharmacopoeia Veterinary:
1. Rule 30A omitted by G.S.R.944 (E), dt. 21-9-1988. Earlier rules 30A and 30AA ins. by Notfn. F. 1-
30/48-G, Dt. 14.4.1952.
2. Ins. by notification No. F 1-30/48, dt. 14-01-1952.
3. Subs. G.S.R. 680 (E) ,dt. 5-12-1980.
4. Ins. by Notfn. No. F. 1-45 4-1-1951.
5. Subs. G.S.R. 604 (E), dt. 24-8-2001.
Drugs and Cosmetics Rules 1945
51
Provided further that the licensing authority shall not allow the import of any drug
having less than sixty per cent residual shelf-life period as on the date of import:
Provided also that in exceptional cases the licensing authority may, for reasons to
be recorded in writing, may allow, the import of any drug having lesser shelf-life
period, but before the date of expiry as declared on the container of the drug.]
1
[32. Packing and labelling of imported drugs. No drug shall be imported unless
it is packed and labelled in conformity with the Rules in Parts IX and X
2
[* * *] and
further conform to the standards laid down in Part XII provided that in the case of
drugs intended for veterinary use, the packing and labelling shall conform to the rules
in Parts IX and X and Schedule F(1)].
3
[32A Packing and Labelling of Homoeopathic medicine. No Homoeopathic
medicine shall be imported unless it is packed and labelled in conformity with the
rules in Part IX-A.]
33. Import of drugs for examination, test or analysis Small quantities of drugs
the import of which is otherwise prohibited under section 10 of the Act may be
imported for the purpose of examination, test or analysis subject to the following
conditions:
(a) No drug shall be imported for such purpose except under a licence in
Form 11;
(b) the licensee shall use the substances imported under the licence
exclusively for purposes of examination, test or analysis and shall carry on such
examination, test or analysis in the place specified in the licence, or in such other
places as the licensing authority may from time to time authorise;
(c) the licensee shall allow any Inspector authorized by the licensing authority
in this behalf to enter, with or without prior notice, the premises where the substances
are kept, and to inspect the premises, and investigate the manner in which the
substances are being used and to take samples thereof;
(d) the licensee shall keep a record of, and shall report to the licensing
authority, the substances imported under the licence, together with the quantities
imported, the date of importation and the name of the manufacturer;
(e) the licensee shall comply with such further requirements, if any, applicable
to the holders of licences for examination, test or analysis as may be specified in
any rules subsequently made under Chapter III of the Act and of which the
licensing authority has given to him not less than one month‘s notice.
1. Subs. by Notfn. No. F. 1-6/62-D (SO 2889), dt. 2-7-1969.
2. Certain words omitted by G.S.R. 661(E), dt. 3-7-1992.
3. Ins. by S. O. No. 2139, dt. 5-6-1972.
Drugs and Cosmetics Rules 1945
52
1
[33A Import of drugs by a Government Hospital or Autonomous Medical
Institution for the treatment of patients.—Small quantities of new drug, as defined in
Rule 122-E, the import of which is otherwise prohibited under section 10 of the Act,
may be imported for treatment of patients suffering from life threatening diseases, or
diseases causing serious permanent disability, or such disease requiring therapies for
unmet medical needs, by a Medical Officer of a Government Hospital or an
Autonomous Medical Institution providing tertiary care, duly certified by the Medical
Superintendent of the Government Hospital, or Head of the Autonomous Medical
Institution, subject to the following conditions, namely:-
(a) no new drug shall be imported for the said purpose except under a licence
in Form 11-A, and the said drug has been approved for marketing in the country
of origin;
(b) the licensee shall use the substances or drugs imported under the licence
exclusively for the purpose of treatment of patients suffering from life threatening
diseases, or diseases causing serious permanent disability, or such diseases
requiring therapies for unmet medical needs, under the supervision of its own
Medical Officers at the place, specified in the licence or at such other places, as
the licensing authority, may from time to time authorise;
(c) the licensee shall allow an Inspector authorised by the licensing authority
in this behalf to enter, with or without prior notice, the premises where the
substances or drugs are stocked, and to inspect the premises and relevant records
and investigate the manner in which the substances or drugs are being used and
to take, if necessary, samples thereof ;
(d) the licensee shall keep a record of, and shall submit the said report half
yearly to the licensing authority, the substances or drugs imported under the
licence, together with the quantities imported and issued to the patients, the date
of importation, the name of the manufacturer, the name and address of the patient
for whom the drug is prescribed and the name of disease;
(e) the licensee shall comply with such other requirements, if any, applicable
to the holders of import licences for import of new drugs for treatment of patients
by Government Hospitals, as may be specified from time to time in any rule
subsequently made under Chapter III of the Act and of which the licensing
authority has given to him not less than one month‘s notice;
(f) the drug shall be stocked under proper storage conditions and shall be
dispensed under the supervision of a registered pharmacist;
(g) the quantity of any single drug so imported shall not exceed 100 average
dosages per patient:
Provided that the licensing authority may, in exceptional circumstances, sanction
the import of drug of a larger quantity.]
34. Application for licence for examination, test or analysis. (1) An application
for a licence for examination, test or analysis shall be made in Form 12 and shall be
made or countersigned by the head of the institution in which, or by a proprietor or
director of the company or firm by which the examination, test or analysis will be
conducted.
1. Ins. by G.S.R 604 (E), dt. 24-8-2001.
Drugs and Cosmetics Rules 1945
53
(2) The licensing authority may require such further particulars to be supplied as
he may consider necessary.
1
[(3) Every application in Form 12 shall be accompanied by a fee of one hundred
rupees for a single drug and an additional fee of fifty rupees for each additional drug.
(4) The fees shall be paid through a challan in the Bank of Baroda, Kasturba
Gandhi Marg, New Delhi-110001 or any other branch or branches of Bank of Baroda,
or any other Bank, as notified, from time to time, by the Central Government, to be
credited under the Head of Account 0210-Medical and Public Health, 04- Public
Health, 104- Fees and Fines.]
2
[34A. Application for licence to import small quantities of new drugs by a
Government Hospital or Autonomous Medical Institution for the treatment of
patients. (1) An application for an import licence for small quantities of a new drug,
as defined in Rule 122-E for the purpose of treatment of patients suffering from life
threatening diseases, or diseases causing serious permanent disability, or such
diseases requiring therapies for unmet medical needs, shall be made in Form 12-AA,
by a Medical Officer of the Government Hospital or Autonomous Medical Institution,
which shall be certified by the Medical Superintendent of the Government Hospital or
Head of the Autonomous Medical Institution, as the case may be.
(2) The licensing authority may require such further particulars to be supplied, as
he may consider necessary.
(3) Every application in Form 12-AA shall be accompanied by a fee of one
hundred rupees for a single drug and an additional fee of fifty rupees for each
additional drug.
(4) The fees shall be paid through a challan in the Bank of Baroda, Kasturba
Gandhi Marg, New Delhi-110001 or any other branch or branches of Bank of Baroda,
or any other Bank, as notified, from time to time, by the Central Government, to be
credited under the Head of Account 0210- Medical and Public Health, 04- Public
Health, 104- Fees and Fine.]
35. Cancellation of licence for examination, test or analysis. (1) A licence for
examination, test or analysis may be cancelled by the licensing authority for breach of
any of the conditions subject to which the licence was issued.
(2) A licensee whose licence has been cancelled may appeal to the Central
Government within three months of the date of the order.
1. Subs. by G.S.R 604 (E), dt. 24-8-2001.
2. Ins. by G.S.R 604 (E), dt. 24-8-2001.
Drugs and Cosmetics Rules 1945
54
1
[35A. Cancellation of licence for import of small quantities of new drugs. (1) A
licence for import of small quantities of a new drug, defined in Rule122E, for the
purpose of the treatment of patients suffering from life threatening diseases, or diseases
causing serious permanent disability, or such diseases requiring therapies for unmet
medical needs, by a Government Hospital or an Autonomous Medical Institution may be
cancelled by the licensing authority for breach of any of the conditions subject to which
the licence was issued or for contravention of any of the provisions of the Act and rules
made thereunder.
(2) A licensee whose licence has been cancelled may appeal to the Central
Government within three months from the date of the receipt of the order, and the Central
Government may after such enquiry into the matter, as it considers necessary and after
giving the appellant an opportunity for representing his views, may pass such orders in
relation thereto, as it thinks fit.]
36. Import of drugs for personal use. Small quantities of drugs, the import of which
is otherwise prohibited under section 10 of the Act, may be imported for personal use
subject to the following conditions:
(i) the drugs shall form part of a passenger‘s bona fide baggage and shall be the
property of, and be intended for, the exclusive personal use of the passenger;
(ii) the drugs shall be declared to the Customs authorities if they so direct;
(iii) the quantity of any single drug so imported shall not exceed one hundred
average doses :
Provided that the licensing authority may in an exceptional case in any individual
case sanction the import of a larger quantity:
2
[Provided further that any drug, imported for personal use but not forming part of
bona fide personal baggage, may be allowed to be imported subject to the following
conditions, namely:
(i) the licensing authority, on an application made to it in Form 12A is
satisfied that the drug is for bona fide personal use;
(ii) the quantity to be imported is reasonable in the opinion of the licensing
authority and is covered by prescription from a registered medical practitioner ;
and
(iii) the licensing authority grants a permit in respect of the said drug in Form
12B.]
3
Previous and next
Questions people ask
Is rule 31 of the Drugs and Cosmetics Rules, 1945 still in force?
No repeal of the Drugs and Cosmetics Rules, 1945 is recorded.